| Prev Close | 85.73 |
| Day Low/High | 0.00 / 0.00 |
| 52 Wk Low/High | 0.00 / 0.00 |
| Exchange | NYSE |
| Div & Yield | N.A. (N.A) |
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Monday as it is currently trading at $127.42, above its previous 52-week high of $126.53 with 1.3 million shares traded as of 9:35 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Tuesday with 2.8 million shares changing hands. It is currently at 2.7 times its average daily volume and trading up $2.55 (+2.1%).
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Friday as it is currently trading at $113.83, above its previous 52-week high of $110.50 with two million shares traded as of 12:25 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) is trading at unusually high volume Thursday with 2.1 million shares changing hands. It is currently at two times its average daily volume and trading up $2.71 (+2.6%).
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Monday as it is currently trading at $105.75, above its previous 52-week high of $101.46 with 374,287 shares traded as of 9:30 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
TheStreet Ratings group highlights 4 stocks pushing the health care sector higher today.
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Friday as it is currently trading at $98.49, above its previous 52-week high of $98.46 with 621,113 shares traded as of 3:50 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals was a winner within the health care sector, rising $1.35 (1.4%) to $97.19 on average volume.
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Monday as it is currently trading at $92.50, above its previous 52-week high of $92.37 with 7,738 shares traded as of 9:30 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Wednesday as it is currently trading at $91.58, above its previous 52-week high of $91.47 with 748,255 shares traded as of 1:10 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals was a leading decliner within the health care sector, falling $1.25 (-1.4%) to $85.24 on average volume.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Watson Pharmaceuticals was a leading decliner within the health care sector, falling $4.28 (-4.9%) to $83.71 on heavy volume.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Micron, Open Text and Watson Pharma have caught my eye.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Watson Pharmaceuticals was a winner within the drugs industry, rising $1.04 (1.2%) to $87.53 on average volume.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Just how the fiscal cliff impacts Mr. Market still remains to be seen, but as the New Year's deadline draws near, you can bet that the drag on stocks will only get stronger.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of A-
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of B
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Tuesday as it is currently trading at $88.58, above its previous 52-week high of $88.33 with 77,907 shares traded as of 10 a.m. ET. Average volume has been 1.1 million shares over the past 30 days.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of B
Here are two generic-drug companies that should hold up well, regardless of the current uncertainty.
Watson Pharmaceuticals (NYSE:WPI) has been reiterated by TheStreet Ratings as a buy with a ratings score of B
Watson Pharmaceuticals (NYSE:WPI) hit a new 52-week high Friday as it is currently trading at $85.29, above its previous 52-week high of $84.59 with 1.3 million shares traded as of 2:55 p.m. ET. Average volume has been 1.1 million shares over the past 30 days.
